On April 29, 2024, the U.S. Food and Drug Administration (FDA) issued a transformative final rule impacting the regulatory landscape for laboratory-developed tests (LDTs).
Read More
With the recent acceleration of NGS implementation in clinical and public health, Advanta Genetics is pleased to announce its recent highlight in the Frontiers in Public Health journal eBook.
Read More
This month, Advanta Genetics is proud to announce its acceptance as a preferred laboratory provider with Southwestern Health Resources (SWHR), a clinically integrated network with 7K+ providers.
Read More
With respiratory illnesses on the rise and a recent surge in Covid-19 cases, it has become more important than ever to exercise care when dealing with exposure to potential respiratory pathogens. Especially with school back in session, it is easy to be vulnerable to what's going around.
Read More
Our Advanta Genetics scientists are excited to introduce their recent research on UTI infections. This newly published article "Advantage of precision metagenomics for urinary tract infection diagnostics" was peer reviewed by scientists from both the California and Minnesota Departments of Health as well as the Centers for Disease Control and Prevention (CDC).
Read More
Advanta Genetics has established a collaboration with molecular diagnostics company Asuragen and Oxford Nanopore Technologies to advance carrier genetic screening by utilizing long-read sequencing technology.
Read More
Advanta Genetics is pleased to announce our Chief Research Officer, Rahul Sharma, Ph.D. HCLD(ABB), is representing Advanta's collaboration with Illumina with a keynote presentation at this year's American Society for Microbiology (ASM) on A Complete Solution for Precision Metagenomics for Infections Disease Testing.
Read More
This month, Advanta Genetics and scientists were brought into the spotlight in a featured article by global genomics leader Illumina for advancements in precision metagenomics for infectious diseases and antibiotic stewardship.
Read More
Advanta Genetics was recently featured in the television series Advancements with celebrity host Ted Danson for outstanding developments in metagenomic next-generation sequencing testing (mNGS) to improve the diagnosis and treatment of complicated infections.
Read More
Congratulations to our Advanta Genetics scientists! Research recently published in the journal Practical Laboratory Medicine has been highlighted by the Centers for Disease Control and Prevention (CDC) in Advanced Molecular Detection for optimizing next-generation sequencing techniques for genomic surveillance of COVID-19.
Read More
mNGS is capable of producting a multitude of possiblities, but most importantly, it can improve timely and accurate identification of the infecting pathogen(s), quickly target treatment and medication therapy, improve antibiotic stewardship, and has shown promise for reducing health care costs, days in the hospital, and in some cases saving lives.
Read More
In recently published article by the journal Advances in Respiratory Medicine, Advanta scientists test samples from patients suspected of respiratory infection and demonstrate evidence that a hybridization-capture-based mNGS workflow allowed the detection of 29 additional respiratory microorganisms versus polymerase chain reaction (PCR).
Read More
In a recent study of 47 samples, Advanta scientists compared metagenomics next generation sequencing (mNGS) testing with standard urine culture testing. The results showed ~50 additional uropathogens detected by mNGS compared to traditional urine culture.
Read More
The CEO and CDO of Advanta Genetics recently co-authored research that addresses the ongoing concern that entrepreneurship education is not preparing students sufficiently well for jobs in the 21st-century.
Read More
Advanta Genetics' Department of Research has recently validated a fast, accurate method to quantify the D- and L- isomers of (meth)amphetamine in human oral fluid.
Read More
Advanta Genetics has fully validated the Illumina COVIDSeq™ assay as a laboratory developed test in line with CLIA and CAP guidelines.
Read More
Advanta Genetics CEO and CDO discuss the risks in grouping experts for organizational performance in recent co-authored publication.
Read More
Advanta's Chief Development Officer, Dave Silberman, Ph.D., proposes a simple formula to improving workplace organizational performance.
Read More
Advanta Genetics is proud to announce that several of our scientists have been accepted to present their work on "Deciphering the Microbiology of Respiratory Infection Using Precision Metagenomics Analysis" at the 2022 Association for Molecular Pathology (AMP) Annual Meeting & Expo in Phoenix, Arizona this November. Their work will also be published in the November 2022 issue of The Journal of Molecular Diagnostics.
Read More
Since the COVID-19 pandemic began, Advanta Genetics has been on the front line of testing and tracking COVID-19 variants. In addition to the hundreds of thousands of PCR and blood antibody COVID-19 tests performed, Advanta was among the first laboratories in the region to perform COVID-19 genetic variant testing for epidemiological tracking.
Read More
Advanta Genetics is pleased to announce that several of our scientists have been accepted to present their work on "Plasma Drug Testing for D&L Isomers of Amphetamine and Methamphetamine" at the International Symposium on Technical Innovations in Laboratory Hematology September in Bologna, Italy.
Read More
Advanta Genetics is honored to be selected to present at the 2022 American Association of Bioanalysts and CRB Symposium in Austin, TX this week. #AABCRB22
Our team has worked hard to showcase the application of qPCR-based SARS-CoV-2 variant detection to complement Next Generation Sequencing with evidence-based data in East Texas. Good luck and congratulations to Dr. Carpenter, Dr. Sharma, and Tyler Vine.
Read More
Fit to perform but unqualified to lead?
Advanta's Chief Development Officer and Forbes Council Member, Dave Silberman, Ph.D. shares insight to a common issue in today's organizational leadership. Find out how to make meaningful movement to benefit your organization.
Read More
In published article "Learning as Cognition: A Developmental Process for Organizational Learning", CEO of Advanta Genetics, Rob Carpenter, MBA, Ph.D., discusses the advantage of joint focused group cognition, and how perspective can influence the development of organizational learning.
Read More